Anixa Biosciences, Inc. (ANIX) vs OnKure Therapeutics, Inc. (OKUR)

A side-by-side comparison of Anixa Biosciences, Inc. and OnKure Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ANIX vs OKUR

growth of $100 · dividends reinvested · last 5y
ANIX -39.4% (-9.5%/yr)OKUR -98.2% (-55.5%/yr)ANIX compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020222023202420252026$61$2
ANIX OKUR

ANIX vs OKUR: by the numbers

  • •OKUR is the larger company ($103M vs $103M market cap).

Metrics side by side

Valuation

MetricANIXOKUR
P/B ratio7.100.60

Profitability

MetricANIXOKUR
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-72.02%-34.11%
ROIC-82.35%-35.98%

Growth (annualized)

MetricANIXOKUR
Total return CAGR (5Y)-8.26%-47.19%

Frequently asked

How have ANIX and OKUR total returns compared?
Over the past 5 years, ANIX delivered -8.26% and OKUR delivered -47.19% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.